Form 4: Repligen Corp Director Carrie Eglinton Manner Reports Acquisition of Restricted Stock Units and Stock Options

Director Carrie Eglinton Manner reports the acquisition of 701 restricted stock units and 1,376 stock options in Repligen Corp on May 16, 2024.

Summary

• On May 16, 2024, Carrie Eglinton Manner, a director of Repligen Corp, acquired 701 restricted stock units (RSUs) at $0.00.
• These RSUs represent a contingent right to receive one share of Repligen Corporation's Common Stock each.
• The RSUs vest on the earlier of May 16, 2025, or the date of the next annual meeting of the company's shareholders.
• Ms. Manner also acquired 1,376 stock options with an exercise price of $171.03.
• These options vest on the earlier of May 16, 2025, or the date of the next annual meeting of the company's shareholders and expire on May 16, 2034.
• Following these transactions, Ms. Manner directly owns 3,493 shares of common stock and 1,376 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option awards to a director, which is a common practice. The vesting schedule suggests a long-term commitment.

Positives

• The acquisition of restricted stock units and stock options by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units and stock options is contingent upon the earlier of May 16, 2025, or the date of the next annual meeting of the company's shareholders, which has not yet been determined.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, in their company's stock. These filings are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future prospects.

Comparison to Industry Standards

• Comparing Repligen's insider ownership to companies like Danaher (DHR) or Thermo Fisher Scientific (TMO) can provide context.
• These larger life sciences companies also have insider transaction reporting, but the scale and frequency may differ based on company size and executive compensation structures.
• Benchmarking the vesting schedules and option terms against industry norms helps assess the attractiveness of the equity compensation.

Stakeholder Impact

• The acquisition of stock options and restricted stock units by a director can positively influence shareholder sentiment, as it aligns the director's interests with those of the shareholders.

Key Dates